Methods for treating premature infants
OwnerRichard Boweninventor
Life of this patent
Estimating the term…
Abstract
Methods of treating premature infants include administering, to an infant, an agent that increases the blood or tissue levels, production, function, or activity of hCG, LH, FSH, GnRH, or activin or that decreases the blood or tissue levels, production, function, or activity of follistatin and inhibin.
Claims16
A method of treating premature infants comprising the step of administering, to an infant, a pharmaceutically effective amount of an agent that increases blood or tissue levels, production, function, or activity of hCG, LH, FSH, GnRH, or activin.
A method of treating premature infants comprising the step of administering, to an infant, a pharmaceutically effective amount of an agent that decreases blood or tissue levels, production, function, or activity of follistatin or inhibin.
A method of treating one or more diseases or conditions associated with infant prematurity comprising the step of administering, to an infant, a pharmaceutically effective amount of an agent that increases blood or tissue levels, production, function, or activity of hCG, LH, FSH, GnRH, or activin.
A method of treating one or more diseases or conditions associated with infant prematurity comprising the step of administering, to an infant, a pharmaceutically effective amount of an agent that decreases blood or tissue levels, production, function, or activity of follistatin or inhibin.
Dependencies are inferred from the claim text.